Investor Type | Firm |
Type of Fund | Private Equity Fund |
Industries | IT (& TMT) • Hardware (& Manufacturing) • Energy • CleanTech • HealthTech (& Fitness) • Material Science • Medical Devices (& Hospital Services) |
Stages | Expansion, MBO/LBO, Acquisition |
Investing | United States • United Kingdom • Canada • Germany • France • Italy • Sweden • China • Netherlands • Denmark • Brazil • Latin America • Austria • Europe • Finland • Norway • Asia • Bulgaria |
Air Liquide Venture Capital (ALIAD) is a venture capital arm of Air Liquide Group, operating as a private equity fund with headquarters at 1455 East Putnam Avenue, Old Greenwich, Connecticut, 06870, United States. ALIAD's investment approach focuses on equity investments primarily in the fields of IT and TMT, Hardware and Manufacturing, Energy, CleanTech, HealthTech and Fitness, Material Science, Medical Devices and Hospital Services. The fund specializes in Expansion, Management Buyouts (MBO), Leveraged Buyouts (LBO), and Acquisition. ALIAD aims to support innovative startups and offers strategic partnerships to entrepreneurs with the potential for solid growth and value creation. By leveraging the larger Air Liquide Group's industry expertise and global reach, ALIAD positions itself as a strategic investor, providing portfolio companies not only with capital but also with access to a wealth of operational experience, technical knowledge, and a broad business network. This synergy allows them to assist in the development and scaling of transformative technologies and businesses. As a part of its investment thesis, ALIAD seeks to identify and invest in companies that can deliver sustainable performance and contribute to a more efficient and environmentally friendly industry landscape, aligning with the broader corporate objectives of Air Liquide Group for innovation driven growth in industry and healthcare.